Here we found that TMPs expressing CD44 contribute to metastatic tumor cell characteristics in part by disrupting the actin cytoskeleton filament structure, inhibiting focal adhesion plaques and cell spreading, reducing contractility, and downregulating adhesion-related signaling measured by phospho-paxillin (Figure 3 and Figure 4). The gene discussed is PXN; the disease is neoplasm.